Determination of raloxifene and its glucuronides in human urine by liquid chromatography–tandem mass spectrometry assay
Authors:
- Tina TrdanTTTina Trdan
- Robert RoškarRRRobert Roškar
- Jurij TronteljJTJurij Trontelj
- Matjaž RavnikarMRMatjaž Ravnikar
- Aleš MrharAMAleš Mrhar
- 1 August 2011
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B
- Vol. 879 (23) , 2323-2331
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Effects of the Selective Estrogen Receptor Modulator Raloxifene on Coronary Outcomes in The Raloxifene Use for the Heart TrialCirculation, 2009
- Development and validation of a liquid chromatography–tandem mass spectrometry assay for determination of raloxifene and its metabolites in human plasmaJournal of Chromatography B, 2007
- Validation and application of a screening method for β 2‐agonists, anti‐estrogenic substances and mesocarb in human urine using liquid chromatography/tandem mass spectrometryRapid Communications in Mass Spectrometry, 2006
- Effect of Raloxifene on the Incidence of Invasive Breast Cancer in Postmenopausal Women with Osteoporosis Categorized by Breast Cancer RiskClinical Cancer Research, 2006
- Skeletal Effects of Raloxifene After 8 Years: Results from the Continuing Outcomes Relevant to Evista (CORE) StudyJournal of Bone and Mineral Research, 2005
- Comparison of effects of the rise in serum testosterone by raloxifene and oral testosterone on serum insulin-like growth factor-1 and insulin-like growth factor binding protein-3Maturitas, 2005
- SPECIES- AND DISPOSITION MODEL-DEPENDENT METABOLISM OF RALOXIFENE IN GUT AND LIVER: ROLE OF UGT1A10Drug Metabolism and Disposition, 2005
- Bioanalytical High-Throughput Selected Reaction Monitoring-LC/MS Determination of Selected Estrogen Receptor Modulators in Human Plasma: 2000 Samples/DayAnalytical Chemistry, 2000
- Pharmacokinetics of raloxifene and its clinical applicationEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1999
- The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal WomenJAMA, 1999